GCM
ANGO icon

Graham Capital Management’s AngioDynamics ANGO Stock Holding History

Graham Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,657
Closed -$119K – 1281
2025
Q1 		$119K Buy
12,657
+1,126
+10% +$11.8K ﹤0.01% 1191
2024
Q4 		$106K Buy
+11,531
New +$84.8K ﹤0.01% 1149
2024
Q3 		– Sell
-10,766
Closed -$65.1K – 1090
2024
Q2 		$65.1K Buy
+10,766
New +$66.4K ﹤0.01% 972
2023
Q1 		– Sell
-75,477
Closed -$1.04M – 1038
2022
Q4 		$1.04M Buy
+75,477
New +$1.05M 0.03% 518

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Graham Capital Management's ANGO Position: Q2 2025 in Review

Graham Capital Management sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 12,657 shares — an estimated $119K sold.

Graham Capital Management first reported a position in ANGO in Q4 2022 and held it in 4 quarters. The position peaked at $1.04M in Q4 2022. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Graham Capital Management reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 12,657 AngioDynamics shares in Q2 2025, an estimated $119K.
  • Graham Capital Management first reported a position in AngioDynamics in Q4 2022 and held it in 4 quarters.
  • Graham Capital Management's AngioDynamics position peaked at $1.04M in Q4 2022.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.